Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M92.5Revenue (TTM) $M24.3Net Margin (%)-131.7Altman Z-Score-8.4
Enterprise Value $M172EPS (TTM) $-0.7Operating Margin %-151.4Piotroski F-Score4
P/E(ttm)--Beneish M-Score-1.5Pre-tax Margin (%)-131.4Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio0.9Cash flow > EarningsN
Price/Sales3.85-y EBITDA Growth Rate %-29.8Current Ratio0.9Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-40.4Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-106.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M45.1ROIC % (ttm)-158.6Gross Margin Increase y-yY

Gurus Latest Trades with ALIM

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

ALIM is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ALIM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BAVP, L.P.10% Owner 2016-04-21Sell478,673$2.59-20.85view
EISWIRTH RICHARD S JRCOO and CFO 2015-12-16Sell46,669$2.31-11.26view
Flynn James E 2015-12-08Buy272,249$3.01-31.89view
Flynn James E 2015-12-03Buy243,252$3-31.67view
Flynn James E 2015-11-06Buy73,250$2.98-31.21view
Flynn James E 2015-10-30Buy16,542$3-31.67view
Flynn James E 2015-10-28Buy59,342$3-31.67view
Flynn James E 2015-10-26Buy60,364$3-31.67view
Flynn James E 2015-10-21Buy390,040$2.97-30.98view
EISWIRTH RICHARD S JRCOO and CFO 2015-10-15Sell13,625$2.69-23.79view

Quarterly/Annual Reports about ALIM:

    News about ALIM:

    Articles On GuruFocus.com
    Alimera Sciences Inc. (ALIM) President and CEO C. Daniel Myers sells 45,523 Shares Mar 16 2011 
    The Most Speculative Stocks on the Market: Harbinger, Kaching Kaching, Alimera Sciences, Star Scient Jul 29 2010 

    More From Other Websites
    Alimera Sciences (ALIM) Shares March Higher, Can It Continue? Jul 27 2016
    Alimera Sciences Pre-Announces Record Second Quarter 2016 Revenue Jul 26 2016
    ALIMERA SCIENCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of... Jul 26 2016
    Alimera Sciences Pre-Announces Record Second Quarter 2016 Revenue Jul 26 2016
    Alimera Sciences (ALIM) Is in Oversold Territory: What's Next? Jul 22 2016
    ETF’s with exposure to Alimera Sciences, Inc. : July 20, 2016 Jul 20 2016
    ALIMERA SCIENCES INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jul 12 2016
    Alimera Sciences to Present at the Cantor Fitzgerald Conference Jul 06 2016
    Alimera Sciences to Present at the Cantor Fitzgerald Conference Jul 06 2016
    ALIMERA SCIENCES INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 27 2016
    Alimera Sciences to Present at the LD Micro Invitational Conference Jun 02 2016
    Alimera Sciences to Present at the LD Micro Invitational Conference Jun 02 2016
    ALIMERA SCIENCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... May 27 2016
    Real World Data In Europe Show Majority Of Diabetic Macular Edema Patients Gain Or Maintain Vision... May 23 2016
    Real World Data In Europe Show Majority Of Diabetic Macular Edema Patients Gain Or Maintain Vision... May 23 2016
    ETF’s with exposure to Alimera Sciences, Inc. : May 19, 2016 May 19 2016
    Alimera Sciences, Inc. :ALIM-US: Earnings Analysis: Q1, 2016 By the Numbers May 18 2016
    ALIMERA SCIENCES INC Financials May 17 2016
    Alimera Sciences to Present at the UBS Global Healthcare Conference May 17 2016
    Alimera Sciences to Present at the UBS Global Healthcare Conference May 17 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)